Researchers analyzed over 5,000 Instagram posts from British motherhood influencers, revealing how “sharenting” raises privacy risks while balancing commercial and personal motivations.
Immunovant’s $450M; Oncopeptides reassesses Pepaxti strategy in Europe; Akebia resubmits kidney drug
Immunovant goes for $450M: Immunovant’s early-stage autoimmune data will lead to a $450 million haul for the New York biotech, about $150 million more than